MEDI PARTNER AS • 965165991 • Fredrikstad • Wholesale trade, except of motor vehicles and motorcycles

This website uses cookies to enhance the user experience.

Goods and trade

/ Purchase and sale

MEDI PARTNER AS

Keywords

pharmaceuticalshospital equipmentorthopedic articles

Organization

CEO: LA
Lise Andrea Setterberg Nossen1986
Chairman of the board: LE
Lars Erik Andersen1960
Years since formation: 29 years; since Mar 12, 1995
Type: Limited company
VAT registered: Yes
Number of employees: 33

Ownership

Number of shares and share classes: 2,400,000; 1 share class
Total number of shareholders: 1; company
Belongs to group of

Financials

Total operating income 2023: 157,070,290; NOK
Annual total result 2023: 6,020,243; NOK
Total equity 2023: 20,134,356; NOK

Last update: Dec 12, 2024

Management

Management / administration

Name	Role	Shares
LA Lise Andrea Setterberg Nossen 1986	Managing Director/CEO	24 % indirectly

Board

Name	Role	Shares
LE Lars Erik Andersen 1960	Chairman	52 % indirectly
MW Mona Wenzell 1964	Board Member	-
LA Lise Andrea Setterberg Nossen 1986	Board Member	24 % indirectly

Others

Name	Role	Shares
B BDO AS	Auditor	-

Top 10 individual shareholders

Name	Role	Shares
LE Lars Erik Andersen 1960	Chairman	52 % indirectly
LA Lise Andrea Setterberg Nossen 1986	Managing Director/CEO, Board Member	24 % indirectly
LA Lasse Setterberg Andersen 1991	-	24 % indirectly

Last update: Jan 9, 2024

Ownership

Company shareholders

Name	Share class	Number of shares	Share
M MEDI PARTNER HOLDING AS	Ordinary shares	2,400,000	100 %

Shares owned by the MEDI PARTNER AS

Name	Share class	Number of shares	Share
N NORENGROS HX AS	Class B shares	700	11.67 %
N NORENGROS AS	Ordinary shares	192	8.31 %
P PG KJØP AS	Ordinary shares	67	2.82 %

Last update: May 24, 2024

Group structure

MEDI PARTNER HOLDING AS
Total operating income 2023: NOK 0
Operating profit 2023: NOK -216,487
Employees: 0

Financials

in NOK

Summary

Year	2023	2022	2021
Total operating income	157,070,290	479,898,636	244,754,049
Annual Total Result	6,020,243	106,117,718	32,174,335
Total assets	81,230,911	185,424,698	109,041,594
Total liabilities	61,096,555	136,310,586	81,045,199
Total equity	20,134,356	49,114,113	27,996,394

P&L

Year	2023	2022	2021
Total operating income	157,070,290	479,898,636	244,754,049
Total operating costs	149,582,320	346,490,281	202,923,166
Operating result	7,487,970	133,408,356	41,830,882
Financial income/costs	354,243	2,658,098	-553,559
Profit before tax	7,842,213	136,066,453	41,277,323
Total tax & extraordinary income/cost	1,821,970	29,948,735	9,102,988
Annual Total Result	6,020,243	106,117,718	32,174,335

Balance overview

Year	2023	2022	2021
Total fixed assets	3,699,454	3,542,438	3,302,123
Total current assets	77,531,457	181,882,260	105,739,471
Total assets	81,230,911	185,424,698	109,041,594
Short term debt	61,096,555	136,310,586	81,045,199
Long term debt	0	0	0
Total liabilities	61,096,555	136,310,586	81,045,199
Contributed capital	3,241,018	3,241,018	3,241,018
Retained earnings	16,893,338	45,873,095	24,755,376
Total equity	20,134,356	49,114,113	27,996,394
Total equity and liabilities	81,230,911	185,424,698	109,041,594

Classification

Category

Goods and trade

/ Purchase and sale

Type of organization

Limited company

Classification of institutional sector

INNL

Domestic sectors

A_IKKE-FIN

Non-financial corporations

2100

Private non-financial incorporated enterprises

Standard industrial classification

G

Main industrial area

Wholesale and retail trade; repair of motor vehicles and motorcycles

46

Activity

Wholesale trade, except of motor vehicles and motorcycles

46.4

Main industrial group

Wholesale of household goods

46.46

Industrial group

Wholesale of pharmaceutical goods

46.460

Industrial group

Wholesale of pharmaceutical goods